ArticleWorld journal of clinical cases2025
Gastrointestinal metastasis from invasive lobular carcinoma following breast cancer treatment: A case report.
Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Simultaneous gastric and colonic metastasis of invasive lobular carcinoma of the breast.Clinical journal of gastroenterology · 2026Article
- Small intestinal metastasis of triple-negative breast cancer mimicking lymphoma: imaging findings and case report.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMetastasis of breast cancer usually affects the lungs, bones, liver, and brain. It rarely spreads to the gastrointestinal tract, and cases with similar endoscopic manifestations are even rarer. Herein, we report a 52-year-old woman presenting with metastatic lobular carcinoma involving the gastrointestinal tract four years following a left mastectomy, chemoradiotherapy, and hormone therapy for lobular carcinoma of the breast. CASE SUMMARY: A 52-year-old woman presented with a history of invasive lobular carcinoma and experienced metastasis of breast cancer to the gastrointestinal tract. The patient underwent a left mastectomy and tumor cells were positive for estrogen receptor (ER) and progesterone receptor (PR), negative for human epidermal growth factor receptor 2 (HER2) and E-cadherin. She did not experience any local or distant recurrences for four years following the mastectomy, chemoradiotherapy, and hormone therapy. However, the patient complained of upper abdominal discomfort and was transferred to our hospital. The endoscopic examination revealed multiple crater-like ulcers scattered throughout the stomach, gastric antrum, and colorectum. Surprisingly, the histology of colorectum lesions was the same as that of gastric metastasis. Gastric tumor cells were positive for GATA-binding protein 3 (GATA3), PR, and ER, negative for HER2. The colorectum tumor cells were positive for GATA3 and ER and negative for cytokeratin 20. Based on the results of immunohistological examination, a final diagnosis of gastrointestinal metastases from breast cancer was established.
conclusionDistinguishing metastatic breast cancer from primary gastrointestinal lesions is crucial for initiating the correct treatment and enhancing the quality of life for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.